medigraphic.com
SPANISH

Anales de Otorrinolaringología Mexicana

Anales de Otorrinolaringología Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 4

<< Back Next >>

Otorrinolaringología 2013; 58 (4)

Intralesional Cidofovir in the Treatment of Laryngeal Paillomatosis. Experience at Hospital Infantil del Estado de Chihuahua

Horcasitas PRA
Full text How to cite this article

Language: Spanish
References: 8
Page: 217-220
PDF size: 435.77 Kb.


Key words:

laryngeal papillomatosis, treatment, cidofovir.

ABSTRACT

Background Recurrent respiratory papilomatosis is the most common benign neoplasm of the larynx, the standard treatment for this disease consists of repeated microsuspension direct laryngoscopy cold steel resection or CO2 laser ablaction of papillomatous growths under general anesthesia.
Objective To communicate the results in five patients with Recurrent respiratory papilomatosis treated with intralesional cidofovir.
Material and method A prospective and observational case series study was done in a secondary care children’s hospital with eight patients with severe recurrent respiratory papillomatosis, all of the patients requiring at least a debulking procedure to mantain airway patiency every two months, five patients have been treated with the injection protocol every three weeks for a total of five injections in each patient. The overall follow up was of six months or more after the last cidofovir injection.
Results It was observed marked improvement in the five patients, none of the patients have needed another debulking procedure, airway patency is normal and the voice in seven of the eight patients had a sustained improvement.
Conclusions Cidofovir is a useful drug in the treatment of laryngeal papillomatosis, but not all patients respond to treatment.


REFERENCES

  1. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008;118:1236-1247.

  2. Mounts P, Kashima H. Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope 1984;94:28-33.

  3. Mounts P, Shah KV. Respiratory papillomatosis: etiological relation to genital tract papillomaviruses. Prog Med Virol 1984;29:90-114.

  4. Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KV. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg 2004;130:711-716.

  5. Armstrong LR, Derkay CS, Reeves WC; RRP Task Force. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 1999;125:743-748.

  6. Derkay CS.Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg 1995;121:1386-1391.

  7. Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, et al. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2003;129:976-982.

  8. Lindman JP, Lewis LS, Accortt N, Wiatrak BJ. Use of the Pediatric Quality of Life Inventory to assess the health-related quality of life in children with recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005;114:499-503.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Otorrinolaringología. 2013;58